Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Layoffs are looming in Switzerland as Novartis announces its plans to cut upwards of 550 full-time positions by the end of ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to support financial flexibility and ...

Psychedelics have demonstrated significant progress, with promising data and increased interest from large companies, ...

Businesses want to be available to provide for employees and be competitive. They want workers to be able to go to the HR ...

Cancerguard, a multi-cancer early detection blood test.

Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, continues his conversation about ...

Tesaro confirmed its litigation against AnaptysBio in the Delaware Chancery Court in a press release on its website, ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship ...

Amid the usual hustle before a big medical conference or industry trade show, editors are often buried under a flood of news ...